Related Experiment Videos
Relevance of tumour necrosis factor alpha gene polymorphism in rheumatic disease
Rheumatology (Oxford, England)
|August 26, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis.
Scandinavian journal of rheumatology·2025
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
The pharmacogenomics journal·2013
Familial Mediterranean fever in Azerbaijani children: a nationwide cohort study of genotype-phenotype association.
Rheumatology (Oxford, England)·2026
Online peer support in rheumatology: a mixed methods exploration of patient and clinician views and experiences.
Rheumatology (Oxford, England)·2026
Macrophage activation syndrome in systemic lupus erythematosus and Still's disease: distinct phenotypes shaped by the underlying diseases.
Rheumatology (Oxford, England)·2026
Mortality and causes of death in patients with Sjögren disease in Western Australia: a population-based study.
Rheumatology (Oxford, England)·2026
Therapeutic plasma exchange in pediatric ANCA-associated vasculitis: a multicenter real-world experience.
Rheumatology (Oxford, England)·2026
Celecoxib plus topical flurbiprofen patch versus celecoxib alone for symptomatic knee osteoarthritis: a randomized controlled trial.
Rheumatology (Oxford, England)·2026
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study.
Therapeutic advances in neurological disorders·2026
Efficacy and safety of interleukin-6 receptor inhibitors in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review and meta-analysis.
Therapeutic advances in neurological disorders·2026